ArticleJournal of magnetic resonance imaging : JMRI2026
Association Between Gas-Free Cerebrovascular Reactivity (CVR) and Cognitive Function in Older Adults With a High Risk for Vascular Dementia.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundVascular cognitive impairment and dementia (VCID) is the second leading cause of dementia. Cerebrovascular reactivity (CVR) is a promising biomarker for VCID. However, CVR is not commonly measured in clinical practice due to logistical difficulties in applying a hypercapnia challenge during MR imaging. PURPOSE: To investigate whether CVR measured by intermittent breath modulation (bm-CVR) without hypercapnia gas-inhalation can be a sensitive biomarker in VCID. STUDY TYPE: Prospective cohort study. SUBJECTS: Eighty-two participants (aged 66.8 ± 6.8 years, 54 females, 28 males) with normal cognition (N = 36), mild cognitive impairment (MCI, N = 37), or mild dementia (N = 9). FIELD STRENGTH/SEQUENCE: 3.0 T; Blood-oxygenation-level-dependence (BOLD) MRI. ASSESSMENT: CVR was measured with BOLD MRI using intermittent breath modulation. Cognitive function was measured with Montreal Cognitive Assessment (MoCA) score, cognitive domains scores, and a global composite cognitive score. Physical function was measured with gait-speed and chair-stand test scores. STATISTICAL TESTS: Multi-linear regression models were performed within the participants to test the associations between bm-CVR and measures of cognitive and physical functions. A p value < 0.05 was considered significant. Bonferroni multiple comparison correction was performed when multiple cognitive domains were tested.
resultsWhole-brain bm-CVR values were significantly associated with the diagnosis group of normal, MCI, and early dementia (β = -3.00%/mm Hg, 95% confidence interval (CI) [-5.42, -0.58]), and were lower in the impaired participants relative to participants with normal cognition (β = -2.18, CI [-3.91, -0.45]). Bm-CVR was positively associated with global cognition measured by both MoCA (β = 14.73, CI [1.74, 27.73]) and composite cognitive score (β = 2.22, CI [0.77, 3.66]). For domain-specific cognitive scores, bm-CVR was significantly associated with processing speed (β = 3.19, CI [1.36, 5.02]) and language (β = 2.81, CI [0.70, 4.94]), but not with executive function (p = 0.43) or episodic memory (p = 0.79). DATA
conclusionBm-CVR is a sensitive biomarker for VCID. This gas-free CVR method may be a more practical approach than hypercapnia gas-inhalation CVR for characterizing vascular pathology. EVIDENCE LEVEL: 2. TECHNICAL EFFICACY: Stage 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.